AU2001275107A1 - Vitamin d3 analogs as radiosensitizers for the treatment of cancer - Google Patents

Vitamin d3 analogs as radiosensitizers for the treatment of cancer

Info

Publication number
AU2001275107A1
AU2001275107A1 AU2001275107A AU7510701A AU2001275107A1 AU 2001275107 A1 AU2001275107 A1 AU 2001275107A1 AU 2001275107 A AU2001275107 A AU 2001275107A AU 7510701 A AU7510701 A AU 7510701A AU 2001275107 A1 AU2001275107 A1 AU 2001275107A1
Authority
AU
Australia
Prior art keywords
radiosensitizers
analogs
vitamin
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275107A
Inventor
David A. Gewirtz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virginia Commonwealth University
Original Assignee
Virginia Commonwealth University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Commonwealth University filed Critical Virginia Commonwealth University
Publication of AU2001275107A1 publication Critical patent/AU2001275107A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001275107A 2000-05-30 2001-05-30 Vitamin d3 analogs as radiosensitizers for the treatment of cancer Abandoned AU2001275107A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20729000P 2000-05-30 2000-05-30
US60/207,290 2000-05-30
PCT/US2001/017752 WO2001091794A2 (en) 2000-05-30 2001-05-30 Vitamin d3 analogs as radiosensitizers for the treatment of cancer

Publications (1)

Publication Number Publication Date
AU2001275107A1 true AU2001275107A1 (en) 2001-12-11

Family

ID=22769916

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275107A Abandoned AU2001275107A1 (en) 2000-05-30 2001-05-30 Vitamin d3 analogs as radiosensitizers for the treatment of cancer

Country Status (3)

Country Link
US (1) US20020137731A1 (en)
AU (1) AU2001275107A1 (en)
WO (1) WO2001091794A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007501865A (en) * 2003-06-11 2007-02-01 ノバセア インコーポレイティッド Cancer therapy with active vitamin D compounds in combination with radiotherapy drugs and radiotherapy
US20070275934A1 (en) * 2004-05-10 2007-11-29 Curd John G Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments
US20070299041A1 (en) * 2004-05-26 2007-12-27 Cedars-Sinai Medical Center Induction of innate immunity by vitamin d3 and its analogs
AU2006292482A1 (en) * 2005-09-16 2007-03-29 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating or preventing cancer using pyridine carboxaldehyde pyridine thiosemicarbazone radiosensitizing agents
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
WO2011146635A1 (en) * 2010-05-21 2011-11-24 North Texas Medical Associates Malignant neoplasm treatment protocol
US20130210779A1 (en) * 2012-02-15 2013-08-15 The Washington University Method of identifying triple negative breast cancer
ES2855142T3 (en) 2012-03-23 2021-09-23 Array Biopharma Inc Compounds for use in the treatment of brain metastases in a patient with ErbB2 + breast cancer
RU2524419C1 (en) * 2013-07-02 2014-07-27 Федеральное государственное бюджетное учреждение "Российский онкологический научный центр имени Н.Н. Блохина" Российской академии медицинских наук (ФГБУ "РОНЦ им. Н.Н. Блохина" РАМН) Method for integrated treatment of early anal squamous cell carcinoma
CN111450104A (en) * 2020-05-22 2020-07-28 中国人民解放军第二军医大学 Application of vitamin D in preventing and treating intestinal injury caused by radiation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69522589T2 (en) 1994-06-07 2002-04-18 Teijin Ltd Vitamin D3 derivatives and a process for their preparation
EP0981523B1 (en) 1997-05-16 2005-12-07 Woman & Infants Hospital Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof
EP0981514B1 (en) 1997-05-16 2006-04-05 Woman & Infants Hospital 3-epi vitamin d2 compounds and uses thereof
CA2292734A1 (en) 1997-06-06 1998-12-10 Wisconsin Alumni Research Foundation Use of vitamin d compounds to prevent transplant rejection
US6087350A (en) 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
US6043386A (en) 1998-06-03 2000-03-28 John Hopkins University Non-calcemic, antiproliferative, transcriptionally active 24-fluorinated hybrid analogs of 1α,-25-dihydroxy vitamin D3
US6218430B1 (en) 1998-08-24 2001-04-17 Ligand Pharmaceuticals Incorporated Vitamin D3 mimics
WO2001034199A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer

Also Published As

Publication number Publication date
WO2001091794A3 (en) 2002-08-22
US20020137731A1 (en) 2002-09-26
WO2001091794A2 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
ZA200305126B (en) Methods of administering epothilone analogs for the treatment of cancer.
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
HK1097410A1 (en) Analogs of benzoquinone-containing ansamycins for the treatment of cancer
HK1116339A1 (en) Methods of administering epothilone analogs for the treatment of cancer
AU2001282717A1 (en) Cancer treatment by combination therapy
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
AU6048201A (en) Quinazoline derivatives for the treatment of tumours
IL159887A0 (en) Combination therapy for the treatment of cancer
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2001263383A1 (en) Use of pyridinylimidazole carbamate derivate for the manufacture of a medicament for the treatment of cancer
AU2001266838A1 (en) Inhibitors of matriptase for the treatment of cancer
AU2001290165A1 (en) Components of canola for the treatment of cancer
AU2001275107A1 (en) Vitamin d3 analogs as radiosensitizers for the treatment of cancer
AU2002217866A1 (en) Geldanamycin derivatives useful for the treatment of cancer
AU2002320098A1 (en) Dye-azide compounds for dual phototherapy
AU8322401A (en) Indole compounds useful for the treatment of cancer
AU2002353739A1 (en) Therapeutic compounds
AU2003251875A1 (en) Combination therapy for the treatment of neoplasms
HUP0402341A3 (en) Compositions containing thiazol-2-ylamines for the treatment of cancer
AU2003223538A1 (en) Methods for the treatment of cancer
MXPA03006412A (en) Methods of administering epothilone analogs for the treatment of cancer.
AU2001214116A1 (en) Novel paclitaxel derivatives for the treatment of cancer
AU2000265053A1 (en) Bombesin analogs for treatment of cancer